Amedeo Smart

Free Medical Literature Service


 

Amedeo

Head and Neck Cancer

  Free Subscription

Articles published in
Cancer Res
    February 2026
  1. WANG Q, Tan Z, Zheng C, Xu J, et al
    Androgen Receptor Signaling Induces CD8(+) T Cell Dysfunction that is Reversed by Androgen Deprivation Therapy in Male Head and Neck Squamous Cell Carcinoma.
    Cancer Res. 2026 Feb 9. doi: 10.1158/0008-5472.CAN-25-2384.
    >> Share

    January 2026
  2. ZHAO Y, Ou C, Huang H, Wang Y, et al
    IDH1 Reprograms Nucleotide Metabolism by Inducing Chromatin Remodeling and DHODH Transcription to Drive Chemoresistance in Nasopharyngeal Carcinoma.
    Cancer Res. 2026 Jan 22. doi: 10.1158/0008-5472.CAN-25-2313.
    >> Share

    December 2025
  3. BAO L, Li K, Fan Y, Ge Z, et al
    Drp1 Interaction with BIP Maintains Mitochondrial Dynamic Equilibrium to Promote Anoikis Resistance and Metastasis in Nasopharyngeal Carcinoma.
    Cancer Res. 2025 Dec 15. doi: 10.1158/0008-5472.CAN-25-0622.
    >> Share

    November 2025
  4. MOHAMMAD MIRZAEI N, Hur C, Terry MB, Dalerba P, et al
    Modeling Early-Onset Cancer Kinetics Reveals Changes in Underlying Risk and the Impact of Population Screening.
    Cancer Res. 2025;85:4558-4570.
    >> Share

    October 2025
  5. CHAKRABORTY AK, Kroehling L, Raut RD, Choudhury C, et al
    LSD1 Inhibition Induces MHC-I and Dendritic Cell Activation to Promote Antitumor Immunity in Head and Neck Squamous Cell Carcinoma.
    Cancer Res. 2025 Oct 9. doi: 10.1158/0008-5472.CAN-24-3239.
    >> Share

    September 2025
  6. ZHANG D, Hu J, Zhu G, Liu C, et al
    CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma.
    Cancer Res. 2025 Sep 24. doi: 10.1158/0008-5472.CAN-24-3866.
    >> Share

  7. OLEINIK NV, Atilgan FC, Kassir MF, Lee HG, et al
    Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression.
    Cancer Res. 2025;85:3313-3334.
    >> Share

    August 2025
  8. ROY S, Miyauchi S, Jones RN, Kim SS, et al
    HPV E5 Mediates Resistance to Chemotherapy and Radiation by Promoting a Stem Cell-Like Phenotype in Head and Neck Squamous Cell Carcinoma.
    Cancer Res. 2025 Aug 21. doi: 10.1158/0008-5472.CAN-24-3989.
    >> Share

  9. CONTICELLI D, Volante M, Pietrantonio F, Orru C, et al
    AREG and EREG Are Predictive Biomarkers of Response to EGFR Inhibition in Gastroesophageal Cancer.
    Cancer Res. 2025;85:3111-3122.
    >> Share

    June 2025
  10. ZHANG Y, Li J, Guo X, Gao Z, et al
    Tumor-Specific MHC-II Activates CD4+ and CD8+ T cells in Head and Neck Squamous Cell Carcinoma to Boost Immunotherapy Efficacy.
    Cancer Res. 2025 Jun 20. doi: 10.1158/0008-5472.CAN-24-4383.
    >> Share

  11. KOSHIZUKA K, Wu X, Sato K, Vo PTT, et al
    Genome-Wide CRISPR Screening Reveals that mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer.
    Cancer Res. 2025 Jun 6. doi: 10.1158/0008-5472.CAN-24-3785.
    >> Share

  12. YANG J, Chen F, Fu Z, Yang F, et al
    Blocking the TCA Cycle in Cancer Cells Potentiates CD36+ T-cell-Mediated Antitumor Immunity by Suppressing ER Stress-Associated THBS2 Signaling.
    Cancer Res. 2025;85:2014-2026.
    >> Share

    May 2025
  13. ZHENG Y, Chen Y, Meng X, Zhang L, et al
    FADD Functions as an Oncogene in Chr11q13.3-Amplified Head and Neck Squamous Cell Carcinoma.
    Cancer Res. 2025;85:1909-1927.
    >> Share

  14. MIMURA K, Yoshida K
    The Genetic Footprint of Tobacco Smoking: Unraveling the Mutational Signatures in Head and Neck Cancer.
    Cancer Res. 2025 May 12. doi: 10.1158/0008-5472.CAN-25-1990.
    >> Share

    April 2025
  15. UM JH, Zheng Y, Mao Q, Nam C, et al
    Genomic and Single-Cell Analyses Characterize Patient-Derived Tumor Organoids to Enable Personalized Therapy for Head and Neck Squamous Cell Carcinoma.
    Cancer Res. 2025 Apr 22. doi: 10.1158/0008-5472.CAN-24-2850.
    >> Share

  16. ZHAN J, Li M, Li L, Zeng TT, et al
    Targeting LTBP2 Derived from Cancer-Associated Fibroblasts Sensitizes Esophageal Squamous Cell Carcinoma to Chemotherapy.
    Cancer Res. 2025 Apr 17. doi: 10.1158/0008-5472.CAN-24-1816.
    >> Share

  17. NIU S, Ma J, Liu S, Li Y, et al
    Cis-regulatory Alterations in FOXP4 Modulate Esophageal Cancer Susceptibility Induced by Chronic Alcohol Exposure.
    Cancer Res. 2025 Apr 14. doi: 10.1158/0008-5472.CAN-24-3839.
    >> Share

  18. MENG L, Wu H, Wu J, Ding P, et al
    Aberrant CircTMEM45A Facilitates Inflammatory Progression of Esophageal Squamous Cell Carcinoma through m5C-Mediated NLRP3 Activation.
    Cancer Res. 2025 Apr 11. doi: 10.1158/0008-5472.CAN-24-4154.
    >> Share

    December 2024
  19. OU Z, Zhu L, Chen X, Liu T, et al
    Hypoxia-Induced Senescent Fibroblasts Secrete IGF1 to Promote Cancer Stemness in Esophageal Squamous Cell Carcinoma.
    Cancer Res. 2024 Dec 11. doi: 10.1158/0008-5472.CAN-24-1185.
    >> Share

    November 2024
  20. ZHANG J, Ni Z, Zhang Y, Guo Y, et al
    DAZAP1 Phase Separation Regulates Mitochondrial Metabolism to Facilitate Invasion and Metastasis of Oral Squamous Cell Carcinoma.
    Cancer Res. 2024;84:3818-3833.
    >> Share

  21. PLITT G, Brewer T, Yehia L, Rabinowitz L, et al
    The Genomic Landscape of Benign and Malignant Thyroid Tumors from Individuals Carrying Germline PTEN Variants Is Distinct from Sporadic Thyroid Cancers.
    Cancer Res. 2024;84:3657-3668.
    >> Share

    August 2024
  22. ZHOU L, Tian J, Wang K, Ma Y, et al
    Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma.
    Cancer Res. 2024 Aug 26. doi: 10.1158/0008-5472.CAN-23-2241.
    >> Share

    July 2024
  23. YANG J, Chen F, Lang L, Yang F, et al
    Therapeutic Targeting of the GLS1-c-Myc Positive Feedback Loop Suppresses Glutaminolysis and Inhibits Progression of Head and Neck Cancer.
    Cancer Res. 2024 Jul 18. doi: 10.1158/0008-5472.CAN-24-0254.
    >> Share

  24. GNANAPRAGASAM A, Kirbizakis E, Li A, White KH, et al
    HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer.
    Cancer Res. 2024;84:2377-2389.
    >> Share

  25. DIAO P, Dai Y, Wang A, Bu X, et al
    Integrative multi-omics analyses identify molecular subtypes of head and neck squamous cell carcinoma with distinct therapeutic vulnerabilities.
    Cancer Res. 2024 Jul 3. doi: 10.1158/0008-5472.CAN-23-3594.
    >> Share

  26. LI B, Hao Y, He H, Fan Y, et al
    CD47-SIRPalpha Blockade Sensitizes Head and Neck Squamous Cell Carcinoma to Cetuximab by Enhancing Macrophage Adhesion to Cancer Cells.
    Cancer Res. 2024 Jul 3. doi: 10.1158/0008-5472.CAN-24-0176.
    >> Share

    May 2024
  27. BAKER AM, Nageswaran G, Nenclares P, Ronel T, et al
    FUME-TCRseq Enables Sensitive and Accurate Sequencing of the T-cell Receptor from Limited Input of Degraded RNA.
    Cancer Res. 2024;84:1560-1569.
    >> Share

  28. MENG X, Zheng Y, Zhang L, Liu P, et al
    Single-cell analyses reveal the metabolic heterogeneity and plasticity of the tumor microenvironment during head and neck squamous cell carcinoma progression.
    Cancer Res. 2024 May 8. doi: 10.1158/0008-5472.CAN-23-1344.
    >> Share

    January 2024
  29. LI C, Guo H, Zhai P, Yan M, et al
    Spatial and Single-Cell Transcriptomics Reveal a Cancer-Associated Fibroblast Subset in HNSCC That Restricts Infiltration and Antitumor Activity of CD8+ T Cells.
    Cancer Res. 2024;84:258-275.
    >> Share

    December 2023
  30. SHI Q, Xu G, Jiang Y, Yang J, et al
    Phospholipase PLCE1 promotes transcription and phosphorylation of MCM7 to drive tumor progression in esophageal cancer.
    Cancer Res. 2023 Dec 20. doi: 10.1158/0008-5472.CAN-23-1633.
    >> Share

    October 2023
  31. SMITH AE, Chan S, Wang Z, McCloskey A, et al
    Tipifarnib Potentiates the Antitumor Effects of PI3Kalpha Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity.
    Cancer Res. 2023;83:3252-3263.
    >> Share

  32. LEE RH, Johnson DE, Grandis JR
    To Tip or Not to Tip: A New Combination for Precision Medicine in Head and Neck Cancer.
    Cancer Res. 2023;83:3162-3164.
    >> Share

    September 2023
  33. SFANOS KS
    Intratumoral Bacteria as Mediators of Cancer Immunotherapy Response.
    Cancer Res. 2023;83:2985-2986.
    >> Share

  34. ARBORE G, Albarello L, Bucci G, Punta M, et al
    Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma.
    Cancer Res. 2023;83:2873-2888.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016